PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Peptide delivers 1-2 punch to breast cancer in pre-clinical study

2011-01-04
(Press-News.org) WINSTON-SALEM, N.C. -- Researchers at Wake Forest University Baptist Medical Center (WFUBMC) have discovered what may become a new weapon in the fight against breast cancer. For the first time, a peptide found in blood and tissue has been shown to inhibit the growth of human breast tumors in mice, according to a study recently published in the journal Cancer Research.

Patricia E. Gallagher, Ph.D., and E. Ann Tallant, Ph.D., scientists in the Hypertension and Vascular Research Center at WFUBMC, demonstrated that the peptide angiotensin-(1-7) attacked breast cancer in two ways: by inhibiting the growth of the breast cancer cells themselves and by inhibiting the growth of cancer-associated fibroblasts (CAFs), cells found in the tumor microenvironment -- the tissue surrounding the tumor. CAFs play a vital role in tumor initiation, growth and metastases by providing structural support for the tumor cells and by producing growth factors that help the tumor cells grow.

In this study, mice were injected with human breast cancer cells to form the two most common types of breast tumors -- estrogen-receptor and HER2 sensitive. In women with breast cancer, an estimated 50 to 60 percent have estrogen-receptor sensitive tumors and 20 to 30 percent have HER2 sensitive tumors.

Once the tumors grew, the mice were injected with either angiotensin-(1-7) or saline for 18 days. In the mice treated with angiotensin-(1-7), there was a 40 percent reduction in tumor size as compared to the saline-injected mice, whose tumors grew three times their size at the initiation of treatment. Breast tumor fibrosis also was reduced by 64 to 75 percent in the mice treated with the peptide as compared to the saline-injected mice. Fibrosis is the thickening of the breast tissue around and within the tumor that acts as a scaffold to support the spread of cancer cells.

"This is the first study to show that angiotensin-(1-7) not only inhibits the growth of tumors, but also inhibits breast tumor fibrosis," Gallagher said. "Think of it as a seed and the soil around it – the seed being the tumor and the soil being the fibrosis. You can attack the seed, or you can attack the soil, or do both, and our drug does both."

The tumor microenvironment is especially important when the cancer has metastasized, Tallant said, because drugs that are effective for treating the primary tumor often are not effective in treating a tumor growing in a different part of the body. "Our findings also suggest that angiotensin-(1-7) may enhance the effect of chemotherapeutic agents when administered in combination with other drugs by altering the microenvironment in which the tumor grows," she said.

"Because the safety of angiotensin-(1-7) was established here at Wake Forest Baptist in a recently completed trial in patients with different types of solid tumors, we hope to go to clinical trials for breast cancer relatively soon," Gallagher said.

Gallagher's and Tallant's initial research conducted at the Comprehensive Cancer Center at Wake Forest Baptist showed that angiotensin-(1-7) inhibited the growth of vascular smooth muscle cells, the cells that surround blood vessels and regulate blood pressure. Previous studies showed that patients treated with drugs to reduce blood pressure and increase angiotensin-(1-7), also had a smaller chance of developing cancer. Based on this information, Gallagher and Tallant studied the effect of the peptide on lung cancer and discovered that angiotensin-(1-7) inhibited the growth of lung tumors in mice, as well as reduced the supply of blood vessels to the growing tumor. Their latest study, as reported in Cancer Research, now shows additional effects of angiotensin-(1-7).

Both scientists and Wake Forest University Baptist Medical Center hold a patent on the use of angiotensin-(1-7) for the treatment of cancer.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Researchers measure quality of care in oral anticoagulation

2011-01-04
(Boston) - Researchers from Boston University School of Medicine (BUSM) and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range (TTR) should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes. These findings appear in this month's issue of Circulation: Cardiovascular Quality and Outcomes. Oral anticoagulation with warfarin is received by millions of Americans each year to treat blood clots and to prevent strokes. While warfarin is effective, it is difficult to thin a patient's blood ...

New research reveals unexpected biological pathway in glaucoma

2011-01-04
(Baltimore, MD) — In a study published today in the Proceedings of the National Academy of Sciences (Early Edition ahead of print), a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway that appears to contribute to the development of glaucoma and its resulting vision loss. Prior research has suggested that the optic nerve head, the point where the cables that carry information from the eye to the brain first exit the eye, plays a role in glaucoma. In this study, researchers report ...

Wastewater treatment lowers pathogen levels

2011-01-04
Madison, WI DECEMBER 30, 2010 – A recent study by a team of researchers at the University of Arizona has tracked the incident of pathogens in biosolids over a 19 year period in one major U.S. city. In the same study, the researchers also analyzed pathogen levels in biosolids at 18 wastewater treatment plants in the United States. Their analysis indicates pathogens levels have dropped since the implementation of federal regulations on treating sewage in 1993. These treatment guidelines have proven to be extremely effective with 94% to 99% of all pathogens in biosolids ...

Advancements in fertility preservation provide oncology patients new options

2011-01-04
ROCHESTER, Minn. -- Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years. The good news, according to an article in the January issue of Mayo Clinic Proceedings (http://www.mayoclinicproceedings.com ), is that techniques to harvest and store reproductive cells ...

Anti-bullying program reduces malicious gossip on school playgrounds

2011-01-04
Elementary school students who participated in a three-month anti-bullying program in Seattle schools showed a 72 percent decrease in malicious gossip. The study, led by the University of Washington, is the first to show that the widely-used Steps to Respect bullying prevention program can curb children's gossip, an element of playground culture often seen as harmless but capable of causing real harm. "Gossip is an element of bullying, and it can lead to physical bullying," said Karin Frey, a UW research associate professor of educational psychology. "Kids will tell ...

Protein wields phosphate group to inhibit cancer metastasis

Protein wields phosphate group to inhibit cancer metastasis
2011-01-04
HOUSTON - By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology. In addition to highlighting a novel anti-cancer pathway, the team found that the same deactivation of the enzyme called EZH2 is necessary for the formation of bone-forming cells from the stem cells that make them and other tissues. "EZH2 is overexpressed in aggressive solid tumors and tied ...

Mothers key to college-age women receiving HPV vaccine

2011-01-04
COLUMBUS, Ohio -- Even after young women reach adulthood, their mothers can play a key role in convincing them to receive the human papillomavirus (HPV) vaccine, new research suggests. A study found that college-aged women were more likely to say they had received the HPV vaccine if they had talked to their mother about it. "Mothers talking to their daughters were an important factor in whether young women were vaccinated," said Janice Krieger, lead author of the study and assistant professor of communication at Ohio State University. "It is an encouraging finding, ...

Some banks help keep mortgage holders out of default, studies find

2011-01-04
COLUMBUS, Ohio – While the nation's foreclosure crisis has focused blame on bad loan practices by some lenders, new research shows how some banks may have actually reduced the default risk of their homebuyers. Researchers found that low-income homeowners who received a mortgage from a local lender were less likely to default on their loans than are those who borrowed from a more distant bank or mortgage company. Even if two similar homeowners received the same home loan, with the same interest rate, the one who got the loan at the local lender might be better off in ...

Parallels between cancers, infection suppression reported

2011-01-04
Tiny parasitoid wasps can play an important role in controlling the populations of other insect species by laying their eggs inside the larvae of these species. A newly hatched wasp gradually eats the host alive and takes over its body. The host insect is far from defenseless, however. In Drosophila (fruit flies), larvae activate humoral immunity in the fat body and mount a robust cellular response that encapsulates and chokes off the wasp egg. New research by Dr. Shubha Govind, professor of biology at The City College of New York, and colleagues reveals parallels ...

Care of late-preterm preemies may be insufficient

2011-01-04
MAYWOOD, Ill. – In the last 15 years the U.S has seen a sharp increase in the number of babies born as late-preterm infants, between 34 and 37 weeks' gestation. This is approximately 400,000 children each year, comprising over 70 percent of all preterm births. Often, late-preterm infants are treated the same as full-term infants since they are commonly a similar size and weight. Growing research is showing that this can be detrimental to a late-preterm infant's health and frequently results in readmission to the hospital within the first month of life. "Late-preterm infants ...

LAST 30 PRESS RELEASES:

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

Association of state cannabis legalization with cannabis use disorder and cannabis poisoning

Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

[Press-News.org] Peptide delivers 1-2 punch to breast cancer in pre-clinical study